Circulating vitamin E and cardiometabolic measures: a Mendelian randomization analysis

Area of Science:

• Nutritional Epidemiology
• Cardiovascular Genetics
• Mendelian Randomization

Background:

• Observational studies suggest vitamin E may reduce cardiometabolic disease risk.
• Conflicting results and confounding factors limit observational study conclusions.
• Causality between vitamin E and cardiometabolic diseases requires robust investigation.

Purpose of the Study:

• To investigate the causal relationship between circulating vitamin E and cardiometabolic diseases.
• To utilize Mendelian randomization to overcome confounding factors in observational studies.
• To examine the association between genetically elevated vitamin E and coronary artery disease risk.

Main Methods:

• Employed a Mendelian randomization study design.
• Extracted summary-level data from relevant consortia.
• Utilized three single nucleotide polymorphisms as instrumental variables.

Main Results:

• A one-standard deviation increase in vitamin E was causally linked to increased coronary artery disease risk (OR 3.16).
• Elevated vitamin E showed significant associations with adverse lipid profiles: increased LDL, total cholesterol, and triglycerides.
• A significant decrease in high-density lipoprotein cholesterol was observed with higher vitamin E levels.

Conclusions:

• Genetically elevated vitamin E levels are associated with an increased risk of coronary artery disease.
• Findings suggest an adverse causal relationship between circulating vitamin E and cardiovascular health.
• Vitamin E's role in cardiometabolic disease prevention may be more complex than previously assumed.